Genetic insights into non-syndromic Tetralogy of Fallot
Open accessThe DOI matches its Crossref record; 77 of the 80 references it cites were found in a registry or an index; 17 of the 24 sources its claims cite were checked for support.
Abstract
Congenital heart defects (CHD) include structural abnormalities of the heart or/and great vessels that are present at birth. CHD affects around 1% of all newborns worldwide. Tetralogy of Fallot (TOF) is the most prevalent cyanotic congenital cardiac abnormality, affecting three out of every 10,000 live infants with a prevalence rate of 5-10% of all congenital cardiac defects. The four hallmark characteristics of TOF are: right ventricular hypertrophy, pulmonary stenosis, ventricular septal defect, and overriding aorta. Approximately 20% of cases of TOF are associated with a known disease or chromosomal abnormality, with the remaining 80% of TOF cases being non-syndromic, with no known aetiology. Relatively few TOF patients have been studied, and little is known about critical causative genes for non-syndromic TOF. However, rare genetic variants have been identified as significant risk factors for CHD, and are likely to cause some cases of TOF. Therefore, this review aims to provide an update on well-characterized genes and the most recent variants identified for non-syndromic TOF.
Overview
CoChat Summary
TL;DR
This mini-review updates the genetic basis of non-syndromic Tetralogy of Fallot (TOF), emphasizing rare variants in NOTCH1, FLT4, and cardiac transcription factors. It concludes that non-syndromic TOF is genetically heterogeneous, with many variants requiring functional validation and larger cohorts.
Key findings
- TOF is the most common cyanotic congenital heart defect, affecting 3 per 10,000 live births and comprising 5–10% of all congenital heart defects; about 20% of TOF cases are syndromic, while about 80% are non-syndromic with no identified aetiology.
- In whole-exome sequencing of 829 TOF patients, the NOTCH1 locus followed by FLT4 was the most common site of genetic variants leading to non-syndromic TOF, with variants in these genes detected in about 7% of TOF cases; analysis of 811 TOF probands found 14 FLT4 loss-of-function variants.
- Other reported variants include NKX2.5 R25C and E21E in a Moroccan non-syndromic TOF cohort; JAG1 variants in 3% (2/94) of TOF cases and JAG1 c.765C>T in 60.2% of Iranian TOF patients versus 5.7% of controls; eight ultra-rare missense NOTCH1 variants in a 175-member TOF cohort; and a ZFPM2/FOG2 E1148K mutant with GATA4 interaction reduced by 50% compared with wild-type.
- Emerging candidate genes include KDR, IQGAP1, and GDF1, whose loss of function may cause CHD/TOF; 16 additional patients had pathogenic/likely pathogenic variants in 16 CHD genes (11 loss of function and five missense), one patient had loss-of-function variants in ASXL1 and PSMD12, and a de novo SMARCC2 variant was found in TOF patients.
Methods
- Narrative mini-review synthesizing published genetic studies of non-syndromic TOF; no primary data collection is reported.
- Evidence reviewed includes whole-exome sequencing cohorts, exome sequence analyses, variant screens, bioinformatic predictions, and functional testing of selected variants.
- Main analysis is a qualitative synthesis of gene/variant associations, protein interactions, and pathways such as NOTCH, FLT4/VEGFR3, and cardiac transcription factors.
Limitations
- The paper states that relatively few TOF patients have been studied, little is known about critical causative genes for non-syndromic TOF, and the precise mechanisms of FLT4 and NOTCH1 variants remain unknown.
- The paper repeatedly notes that many new variants require further functional validation and larger patient cohorts, and that genotype–phenotype associations need more research.
- Evident from the text: as a mini-review, no systematic search or meta-analysis is described, and some cited findings come from small samples (e.g., 94 TOF cases, a 175-member cohort) or await clinical confirmation.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
14 Valid · 1 Not valid · 6 Not checked · 7 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Recent analysis of exome sequencing data from 811 TOF probands has found 14 FLT4 loss of function variants (Reuter et al., 2019).”
§ Genetic insights into non-syndromic Tetralogy of Fallot > Introduction > FLT4
What the sources say
- Disputedcites Reuter et al., 2019 matched to “Haploinsufficiency of vascular endothelial growth factor related signaling genes is associated with tetralogy of Fallot” (2019) sourceExperimental — accuracy not yet measured
The Results section, “Rare FLT4 variants associated with tetralogy of Fallot” (page unavailable), reports genome sequencing of 175 TOF individuals and seven FLT4 loss-of-function variants—not exome sequencing of 811 probands and 14 such variants. The Discussion likewise distinguishes this study’s genome sequencing from a previous exome-sequencing study. (LLM, conf=0.89)
Checked by a reasoning model — may be wrong.
plainn = 811- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Rare, de novo genetic variations have been found as substantial factors in TOF (Jin et al., 2017).”
§ Genetic insights into non-syndromic Tetralogy of Fallot > Introduction > Genetics of TOF
What the sources say
- Partly supportedcites Jin et al., 2017 matched to “Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands” (2017) sourceExperimental — accuracy not yet measured
The Results section on FLT4 and tetralogy of Fallot reports two de novo FLT4 loss-of-function mutations and says 9 of 10 probands with FLT4 loss-of-function mutations had TOF. But eight FLT4 mutations were inherited, and the paper does not establish that de novo variants are a substantial factor in TOF overall. (LLM, conf=0.83)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Furthermore, eight ultra-rare missense NOTCH1 variants were found in the investigation of a 175-member TOF cohort in a study performed by (Manshaei et al., 2020).”
§ Genetic insights into non-syndromic Tetralogy of Fallot > Introduction > NOTCH family
What the sources say
- Supportedcites Manshaei et al., 2020 matched to “Genes and pathways implicated in tetralogy of Fallot revealed by ultra-rare variant burden analysis in 231 genome sequences” (2020) source
The Results section, “Detailed in silico Analysis of Ultra-Rare Missense Variants in NOTCH1 and Other Genes,” states that all eight ultra-rare missense NOTCH1 variants were identified among the 175 individuals with TOF. This directly supports the cited claim. (LLM, conf=0.95)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Variants in these genes are detected in about 7% of TOF cases (Page et al., 2019).”
§ Genetic insights into non-syndromic Tetralogy of Fallot > Introduction > Genetics of TOF
What the sources say
- Supportedcites Page et al., 2019 matched to “Whole exome sequencing reveals the major genetic contributors to nonsyndromic tetralogy of Fallot” (2019) source
The TOF susceptibility variants section reports NOTCH1 variants in 4.5% of the cohort, and the FLT4 section reports FLT4 variants in 2.4%. Together, that is 6.9%, or about 7%, of this nonsyndromic TOF cohort. (LLM, conf=0.93)
plainstates an associationn = 829- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“As a result, two variants, the p. C607Y and p. N1875S, recognised in TOF patients who underwent functional testing, were found to affect canonical NOTCH1 signalling (Page et al., 2019).”
§ Genetic insights into non-syndromic Tetralogy of Fallot > Introduction > NOTCH family
What the sources say
- Supportedcites Page et al., 2019 matched to “Whole exome sequencing reveals the major genetic contributors to nonsyndromic tetralogy of Fallot” (2019) source
In “Evidence of Pathological Consequences for NOTCH1 Variants,” the paper reports that p.C607Y significantly reduced RBPJ-dependent NOTCH signaling. The continuation of that results passage reports that p.N1875S also reduced signaling and concludes that two variants identified in patients and subjected to functional testing affected canonical NOTCH1 signaling. (LLM, conf=0.95)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
13 more claims · 6 with their cited sources checked
Create a free account to see all 28 claims and to verify the 2 references still open.
- It may state two separate claims as one. 6
- Probably not a substantial claim. 4
- Borderline: one of the tests for a substantial claim is unclear. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“JAG1 variants, producing functionally relevant sequence changes, were detected in 3% (2/94) of TOF cases.”
§ Genetic insights into non-syndromic Tetralogy of Fallot > Introduction > New variants yet to be confirmed
Reported 3 · recomputed 2.12766
Citations
Cites
The incidence of congenital heart disease.
Hoffman, J. I. E., & Kaplan, S. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01886-7 · Cited by 6,099 · cited 1×
“Congenital heart defects (CHD) are structural malformations of the heart or/and great vessels which affect about 1% of live born infants (Hoffman and Kaplan, 2002).”
BackgroundVEGF receptor signalling ? in control of vascular function
Olsson, A.-K., Dimberg, A., Kreuger, J., & Claesson-Welsh, L. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1911 · Cited by 3,122
Marino, B. S., Lipkin, P. H., Newburger, J. W., Peacock, G., Gerdes, M., Gaynor, J. W., Mussatto, K. A., Uzark, K., Goldberg, C. S., Johnson, W. H., et al. (2012) · Circulation · doi:10.1161/cir.0b013e318265ee8a · Cited by 1,608
Mutations in NOTCH1 cause aortic valve disease
Garg, V., Muth, A. N., Ransom, J. F., Schluterman, M. K., Barnes, R., King, I. N., Grossfeld, P. D., & Srivastava, D. (2005) · Nature · doi:10.1038/nature03940 · Cited by 1,509
Oechslin, E. N., Attenhofer Jost, C. H., Rojas, J. R., Kaufmann, P. A., & Jenni, R. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00755-5 · Cited by 1,211
Lyons, I., Parsons, L. M., Hartley, L., Li, R., Andrews, J. E., Robb, L., & Harvey, R. P. (1995) · Genes & Development · doi:10.1101/gad.9.13.1654 · Cited by 1,141
Bruneau, B. G., Nemer, G., Schmitt, J. P., Charron, F., Robitaille, L., Caron, S., Conner, D. A., Gessler, M., Nemer, M., Seidman, C. E., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00493-7 · Cited by 1,061
Notch signaling: simplicity in design, versatility in function
Andersson, E. R., Sandberg, R., & Lendahl, U. (2011) · Development · doi:10.1242/dev.063610 · Cited by 950
Congenital Heart Defects in Europe: Prevalence and Perinatal Mortality, 2000 to 2005
Dolk, H., Loane, M., Garne, E., & a European Surveillance of Congenital Anomalies (EUROCAT) Working Group (2011) · Circulation · doi:10.1161/circulationaha.110.958405 · Cited by 944
De novo mutations in histone-modifying genes in congenital heart disease
Zaidi, S., Choi, M., Wakimoto, H., Ma, L., Jiang, J., Overton, J. D., Romano-Adesman, A., Bjornson, R. D., Breitbart, R. E., Brown, K. K., et al. (2013) · Nature · doi:10.1038/nature12141 · Cited by 934 · cited 1×
“Whole Exome Sequencing (WES) has been used effectively to find new candidate genes for CHD (Zaidi et al., 2013; Al Turki et al., 2014; Homsy et al., 2015); and (Sifrim et al.”
Method
Research works printed but not linked: 1
- Senst B. Kumar A. Diaz R. R. Cardiac surgery. In: Treasure island (FL), Tampa, Florida, United States: StatPearls Publishing. 2022, StatPearls [internet].
Cited by
Functions of cilia in cardiac development and disease
Qureshi, W. M. S., & Hentges, K. E. (2023) · Annals of Human Genetics · doi:10.1111/ahg.12534 · Cited by 13
Self-citationTetralogy of Fallot: variants of MYH6 gene promoter and cellular functional analyses
Zuo, J.-Y., Chen, H., Yang, Q., Liu, Z.-G., & He, G. (2023) · Pediatric Research · doi:10.1038/s41390-023-02955-x · Cited by 13
Congenital heart diseases (CHDs) and forensic investigations: Searching for the cause of death
Sessa, F., Chisari, M. G., Salerno, M., Esposito, M., Zuccarello, P., Capasso, E., Scoto, E., & Cocimano, G. (2024) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2024.104907 · Cited by 13
RNA binding proteins in cardiovascular development and disease
Verma, S. K., & Kuyumcu‐Martinez, M. N. (2024) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2024.01.007 · Cited by 9
Harvey, D. C., Verma, R., Sedaghat, B., Hjelm, B. E., Morton, S. U., Seidman, J. G., & Kumar, S. R. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1249605 · Cited by 5
Metadata
- Authors
- Althali, N. J., & Hentges, K. E.
- Affiliations
- Manchester Academic Health Science Centre (GB)
- Corresponding author
- Hentges, Kathryn E.
- Venue
- Frontiers in Physiology
- Publisher
- Frontiers Media SA
- Published
- 2022-10-06
- Volume
- 13
- Pages
- 1012665-1012665
- ISSN
- 1664-042X (ISSN-L)
- PMC
- PMC9582763
- OpenAlex
- W4303184717
- Cited by
- 32
- References
- 80
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 12 · 2023: 5
- FWCI
- 0.73
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Physiology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- British Heart Foundation
- Saudi Arabian Cultural Bureau
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Congenital Heart Disease Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- tetralogy of Fallot, cyanotic congenital heart disease, genetic variants, risk genes, right ventricular hypertrophy, pulmonary stenosis, ventricular septal defect, overriding aorta, rare variants
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
